Contacts | Faculty & Staff | Graduate Studies | Home | Links & Resources | Pharmacy Education | Research | Search

headlines

Research Spotlight

 

Faculty & Staff

A prescription for drug safety in rural hospitals. By Linda Homewood

Doctors miss depression diagnosis in heart patients. By Melanie Fridl Ross

• Faculty
• Donna Berardo
• David Brushwood
• Jessica DeLeon
• Abraham G. Hartzema
• Teresa Kauf
• Carole Kimberlin
• Earlene Lipowski
• Sooyeon Kwon
• L. Douglas Ried
• Richard Segal
• Almut Winterstein
• Emeritus Faculty
• Richard Angorn
• Charles Hepler
• Michael Schwartz
• Affiliate Faculty
• David Angaran
• Barbara Brice
• Judy Davis
• T.J. Grainger-Rousseau
• Robert E. Kamm
• Everett Kelly
• Robert Kilroy
• Frederick Lippman
• Susan Maue
• Lynda McKenzie
• Mary Kay Owens
• Peter M. Pevonka
• James Powers
• Katheryne Richardson
• Wayne Russell
• Michael Stamitoles
• Lowell T. Sterler
• Jodi Sullivan
• Art E. Wharton
• Debbie Wilson
• Jianwei Xuan
• Post Doctorate
• Sonya Snedecor
• Staff
• Shirley Johnson
• Martin Meder
• Kathryn St. Croix

Abraham G. Hartzema PharmD, MSPH, PhD, FISPE

Professor,
Perry A. Foote Eminent Scholar
Chair in Health Outcomes and Pharmacoeconomics

• BS Pharmacy, University of Utrecht
• MSPH, University of Washington
• PharmD, University of Utrecht
• PhD, Social and Administrative Pharmacy, University of Minnesota

Dr. Hartzema's research interests are health outcomes research with an emphasis on pharmacoepidemiology, risk management, economics, program evaluation, and health services research. He has served as principal and co-investigator on major grants from the National Institutes of Health, government entities, foundations and the pharmaceutical industry. He has co-authored and edited three books, two of which are in multiple editions, two monographs, one of which is translated in several languages, and has published and presented more than 100 chapters, journal articles, abstracts and presentations.

Selected Publications :

• Jasti S, Siega-Riz AM, Coigswell ME, Hartzema AG.  Correction for errors in measuring adherence to prenatal multivitamin/mineral supplement use among low income women. J. Nutr;136(2):479-83
  PMID: 16424131 [PubMed - in process]

  • Related Articles
  • Abstract

• Beaver T, Winterstein AG, Ahsan E, Shuster J, Gerhard T, Martin T, Alexander JA, Johnson R, Ejaz A, Hartzema AG. Effectiveness of Nesiritide on dialysis or all-cause mortality in patients undergoing cardiothoracic surgery. Clinical Cardiology 2006;29:18-24.

• Gerhard T, Zineh I, Winterstein AG, Hartzema AG. Pharmacoeconomic modeling of Nesiritide versus Dobutamine for decompensated heart failure. Pharmacotherapy 2006;26(1):34-43.

• Richardson L, Tian L, Voti L, Hartzema AG, Reis I, Fleming LE, MacKinnon J.   The role of teaching hospitals, insurance and race-ethnicity in the management of regional stage breast cancer in Florida. Am J Public Health. 2006 Jan;96(1):160-6.

  • Related Articles
  • Abstract

• Jasti S, Siega-Riz AM, Cogswell ME, Hartzema AG, Bentley ME. Pill count adherence to prenatal multivitamin/mineral supplement use among low-income women. J Nutr. 2005 May;135(5):1093-101.
  PMID: 15867287 [PubMed - indexed for MEDLINE]

  • Related Articles
  • Abstract

• Winterstein AG, Hartzema AG. The development of quality of care indicators for asthma in community pharmacies.  J of Research in Social & Administrative Pharmacy 2005; 1:430-445.

• Zineh I, Gerhard T, Aquilante CL, Beitelhees AL, Beasley BN, Hartzema AG. Availability of Pharmacogenomics-based prescribing information in drug package inserts for currently approved drugs. The Pharmacogenomics Journal 2004:4(6):354-8.

• Hartzema AG. Intranasal vaccine for prevention of influenza in children. Am J Health-Syst Pharm 2004; 61: 1716-1720.

• Kwon S-Y, Hartzema AG, Duncan P, Lai S-M. Disability measures in Stroke:  Relatuionship among the Barthel Index, the Functional Independence Measure, and the Modified Rankin Scale.  Stroke. 2004; 35: 918-23.

• Hendeles L, Hartzema AG.  Levalbuterol is not more cost-effective than Albuterol for COPD.  Letter to the editor. Chest. 2003; 124: 1176.

• Shih, Y-CT, Hartzema AG, Tolleson-Rinehart S.  Labor costs of incontinence care in long-term care. Urology. 2003; 62: 442-446.

• Kettis Lindblad A, Hartzema AG, Jansson L, Feltelius N.  Patients’ views of priority setting for new medications: a qualitative study of patients with rheumatoid arthritis. Scandanavian Journal of Rheumatology 2002; 31: 324-9.

• Grabenstein JD, Guess HA, Hartzema AG, Koch GG, Konrad TR.  Attitudinal factors among adult prescription pecipients associated with choice of where to be vaccinated. Journal of Clinical Epidemiology 2002; 55: 279-284.

• Pradel F, Bush PJ, Hartzema AG.  Children with asthma use of inhalation devices: thechniques, autonomy and perception of ease of use.  Journal for Social and Administrative Pharmacy 2001; 18; 178-184.

• Grabenstein JD, Gues HA, Hartzema AG, Koch GG, Konrad TR.¹ Effect of vaccination by community pharmacists among adult prescription recipients.  Medical Care 2001; 39: 340-8.

• Pradel FG, Hartzema AG, Bush PJ. Asthma selfmanagement: The perspective of childern. Patient Education and Counseling. 2001; 45/3:211-24: 1-14.

• Grabenstein JD, Guess HA, Hartzema AG. People vaccinated by community pharmacists: Descriptive Epidemiology. J Am Pharm Assoc 2001; 41:46-52.

• Hartzema AG, Day RS, Tolleson-Rinehart S, Sleath B, Bush PJ.  Optimizing patient comprehension through medicine information leaflets. Final Report. United States Pharmacopeia, 1999.

• Huang X, Hartzema AG, Kauf TL, Norwood GJ, Raasch RH.  The economic evaluation of antimicrobial therapy for uncomplicated urinary tract infection in women.  Clinical Therapeutics. 1999; 21:1578-1588.